Bill114th CongressFiled Jul 30, 2015Health
S. 1906
Orphan Drug Fairness Act
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in senate (Jul 30, 2015)
Orphan Drug Fairness Act
This bill amends the Patient Protection and Affordable Care Act (PPACA) to exclude sales of any drug or biological product approved by the Food and Drug Administration solely for rare diseases or conditions (orphan drug) from the calculation of the annual fee on manufacturers or importers with branded prescription drug sales exceeding $5 million.
This Act is effective as if included in PPACA.
What just happenedJul 30, 2015
Read twice and referred to the Committee on Finance.
Who’s behind it
Sen. Menendez, Robert [D-NJ](D-NJ)Sponsor
1 cosponsor1 R
1cosponsors1committees2actions1related bills5subjects
- Introduced in SenateJul 30, 2015
- Jul 30, 2015IntroReferral
Read twice and referred to the Committee on Finance.
Finance Committee - Jul 30, 2015IntroReferral10000
Introduced in Senate